Description
A hypoglycemic agent; inhibits KATP channels in primary mouse pancreatic β cells (IC50 = 6.4 nM); induces insulin release from isolated rat pancreatic tissue (EC50 = 40 nM); increases the number of insulin receptors on isolated and purified mouse liver plasma membranes at 5 mg/kg per day for 10 days in the diet; reduces plasma glucose and triglyceride, but not total cholesterol, levels and increases plasma insulin levels in a rat model of diabetes induced by a high-fat diet and STZ at 5 mg/kg, p.o.
Formal name: N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-2-pyrazinecarboxamide
Synonyms: CP 28720|K 4024|TK 1320
Molecular weight: 445.5
CAS: 29094-61-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ion Channel Modulation|Blockers||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias